|4Aug 11, 4:43 PM ET

BIO-TECHNE Corp 4

4 · BIO-TECHNE Corp · Filed Aug 11, 2015

Insider Transaction Report

Form 4
Period: 2015-08-07
Bazan J. Fernando
Chief Technical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2015-08-07+10,00010,000 total
    Exercise: $108.49Exp: 2022-08-07Common Stock (10,000 underlying)
  • Award

    Stock Options (Right to Buy)

    2015-08-07+5,0005,000 total
    Exercise: $108.49Exp: 2022-08-07Common Stock (5,000 underlying)
  • Award

    Restricted Stock Units

    2015-08-07+800800 total
    Common Stock (800 underlying)
Holdings
  • Stock Option (Right to Buy)

    Exercise: $76.02Exp: 2020-07-31Common Stock (10,000 underlying)
    10,000
  • Stock Option (Right to Buy)

    Exercise: $76.02Exp: 2020-07-31Common Stock (15,000 underlying)
    15,000
  • Stock Option (Right to Buy)

    Exercise: $94.35Exp: 2021-08-12Common Stock (15,000 underlying)
    15,000
Footnotes (6)
  • [F1]Vests 3,333 shares on each of 8/1/14 and 8/1/15 and 3,334 shares on 8/1/16.
  • [F2]Vests 3,750 shares on each of 8/1/14, 8/1/15, 8/1/16 and 8/1/17.
  • [F3]Vests 3,750 shares on each of 8/12/15, 8/12/16, 8/12/17 and 8/12/18.
  • [F4]Vests 2,500 shares on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
  • [F5]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
  • [F6]Vests in full or in part if certain performance goals are achieved during each of the 2016, 2017 and 2018 fiscal years.

Documents

2 files
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    BAZAN POWER OF ATTORNEY